Amber Chang

Amber Chang is an experienced professional in drug development, currently serving as a Senior Process Engineer at AstraZeneca, focusing on process development in autologous cell therapy. Previously, Amber held positions as a Scientist at Fate Therapeutics Inc, where they specialized in allogenic cell therapy, and as a Scientist I at BioLegend, concentrating on antibody applications. Amber completed a postdoctoral fellowship at the University of California San Diego, where they worked on the discovery and development of disease biomarkers, and earned an Advanced Certificate in Clinical Research from UC San Diego. Amber holds a PhD in Cell Biology and Anatomy from National Cheng Kung University.